The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
A Novel Cytoplasmic Protein with RNA-binding Motifs Is an Autoantigen in Human Hepatocellular Carcinoma
Open accessAbstract
In hepatocellular carcinoma (HCC), autoantibodies to intracellular antigens are detected in 30–40% of patients. Patients with chronic hepatitis or liver cirrhosis develop HCC, and when this occurs, some patients exhibit autoantibodies of new specificities. It has been suggested that these novel autoantibody responses may be immune system reactions to proteins involved in transformation-associated cellular events. One HCC serum shown to contain antibodies to unidentified cellular antigens was used to immunoscreen a cDNA expression library, and a full length cDNA clone was isolated with an open reading frame encoding 556 amino acids with a predicted molecular mass of 62 kD. The 62-kD protein contained two types of RNA-binding motifs, the consensus sequence RNA–binding domain (CS-RBD) and four hnRNP K homology (KH) domains. This protein, provisionally called p62, has close identity (66–70%) to three other proteins at the amino acid sequence level, and all four proteins may belong to a family having CS-RBD in the NH2-terminal region and four KH domains in the mid-to-COOH– terminal region. The homologous proteins are: KH domain–containing protein overexpressed in cancer (Koc); zipcode binding protein, a protein which binds to a conserved nucleotide element in chicken β-actin mRNA (ZBP1); and a protein which binds to a promoter cis element in Xenopus laevis TFIIIA gene (B3). p62 protein is cytoplasmic in location, and autoantibodies were found in 21% of a cohort of HCC patients. Patients with chronic hepatitis and liver cirrhosis, conditions which are frequent precursors to HCC, were negative for these autoantibodies, suggesting that the immune response might be related to cellular events leading to transformation. However, the possible involvement of p62 autoantigen as a factor in the transformation process remains to be elucidated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Verkerk, A. J. M. H., Pieretti, M., Sutcliffe, J. S., Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Reiner, O., Richards, S., Victoria, M. F., Zhang, F., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90397-h · Cited by 3,481 · cited 1×
“Table I also shows that other KH domain–containing proteins such as FMR1 (42), hnRNP K (43), and hnRNP X (44) showed much lower levels of homology.”
Background
Research works printed but not linked: 43
- Tan, 1991, Autoantibodies in pathology and cell biology, Cell, 67, 841, 10.1016/0092-8674(91)90356-4 · DOI · Paper page
- Tan, 1997, Autoantibodies and autoimmunity: a three-decade perspective. A tribute to Henry G. Kunkel, Ann NY Acad Sci, 815, 1, 10.1111/j.1749-6632.1997.tb52040.x · DOI
- Miyachi, 1978, Autoantibody to a nuclear antigen in proliferating cells, J Immunol, 121, 2228, 10.4049/jimmunol.121.6.2228 · DOI · Paper page
- Bravo, 1987, Cyclin/PCNA is the auxiliary protein of DNA polymerase-δ, Nature, 326, 515, 10.1038/326515a0 · DOI · Paper page
- Chan, 1991, Human autoantibody to RNA polymerase I transcription factor hUBF. Molecular identity of nucleolus organizer region autoantigen NOR-90 and ribosomal RNA transcription upstream binding factor, J Exp Med, 174, 1239, 10.1084/jem.174.5.1239 · DOI
- Gottlieb, 1989, Function of the mammalian La protein: evidence for its action in transcription termination by RNA polymerase III, EMBO (Eur Mol Biol Organ) J, 8, 851, 10.1002/j.1460-2075.1989.tb03446.x · DOI · Paper page
- Reimer, 1987, Autoantibody to RNA polymerase I in scleroderma sera, J Clin Invest, 79, 65, 10.1172/JCI112809 · DOI · Paper page
- Lerner, 1979, Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus, Proc Natl Acad Sci USA, 76, 5495, 10.1073/pnas.76.11.5495 · DOI · Paper page
- Moroi, 1980, Autoantibody to centromere (kinetochore) in scleroderma sera, Proc Natl Acad Sci USA, 77, 1627, 10.1073/pnas.77.3.1627 · DOI · Paper page
- Brenner, 1981, Kinetochore structure, duplication, and distribution in mammalian cells: analysis by human autoantibodies from scleroderma patients, J Cell Biol, 91, 95, 10.1083/jcb.91.1.95 · DOI · Paper page
- Earnshaw, 1987, Molecular cloning of cDNA for CENP-B, the major human centromere, J Cell Biol, 104, 817, 10.1083/jcb.104.4.817 · DOI · Paper page
- Tan, 1988, Antinuclear antibodies (ANAs): Dignostically specific immune markers and clues toward the understanding of systemic autoimmunity, Clin Immunol Immunopathol, 47, 121, 10.1016/0090-1229(88)90066-9 · DOI · Paper page
- Tillman, 1992, Both IgM and IgG anti-DNA antibodies are the products of clonally selective B cell stimulation in (NZB × NZW)F1 mice, J Exp Med, 176, 761, 10.1084/jem.176.3.761 · doi:10.1084/jem.176.3.761
- Radic, 1994, Genetic and structural evidence for antigen selection of anti-DNA antibodies, Annu Rev Immunol, 12, 487, 10.1146/annurev.iy.12.040194.002415 · doi:10.1146/annurev.iy.12.040194.002415 · Paper page
- Burnham, 1972, Antinuclear antibodies in patients with malignancies, Lancet, 2, 2436
- Steiner, 1975, Antinuclear reactivity of sera in patients with leukemia and other neoplastic diseases, Clin Immunol Immunopathol, 4, 374, 10.1016/0090-1229(75)90006-9 · doi:10.1016/0090-1229(75)90006-9
- Thomas, 1983, Antinuclear, antinucleolar, and anticytoplasmic antibodies in patients with malignant melanoma, Cancer Res, 43, 1372
- Wasserman, 1975, Autoantibodies in patients with carcinoma of the breast: Correlation with prognosis, Clin Exp Immunol, 19, 417
- Pupa, 1993, Antibody response against the c-erbB-2 oncoprotein in breast carcinoma patients, Cancer Res, 53, 5864
- Dalmau, 1991, Anti-Hu associated paraneoplasic encephalomyelitis/ sensory neuropathy: a clinical study of 71 patients, Medicine, 71, 59, 10.1097/00005792-199203000-00001 · DOI · Paper page
- Buckanovich, 1997, The neuronal RNA binding protein Nova-1 recognizes specific RNA targets in vitro and in vivo, Mol Cell Biol, 17, 3194, 10.1128/MCB.17.6.3194 · DOI · Paper page
- Covini, 1997, Diversity of antinuclear antibody responses in hepatocellular carcinoma, J Hepatol, 26, 1255, 10.1016/S0168-8278(97)80460-6 · DOI
- Imai, 1992, Nucleolar antigens and autoantibodies in hepatocellular carcinoma and other malignancies, Am J Pathol, 140, 859
- Imai, 1993, Increasing titers and changing specificities of antinuclear antibodies in patients with chronic liver disease who develop hepatocellular carcinoma, Cancer, 71, 26, 10.1002/1097-0142(19930101)71:1<26::AID-CNCR2820710106>3.0.CO;2-N · DOI
- Imai, 1993, Novel nuclear autoantigen with splicing factor motifs identified with antibody from hepatocellular carcinoma, J Clin Invest, 92, 2419, 10.1172/JCI116848 · DOI
- Muro, 1995, A cell-cycle nuclear autoantigen containing WD-40 motifs expressed mainly in S and G2 phase cells, Biochem Biophys Res Commun, 207, 1029, 10.1006/bbrc.1995.1288 · DOI
- Winter, 1992, Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation, Cancer Res, 52, 4168
- Houghton, 1994, Cancer antigens: immune recognition of self and altered self, J Exp Med, 180, 1, 10.1084/jem.180.1.1 · DOI · Paper page
- Sahin, 1995, Human neoplasms elicit multiple specific immune responses in the autologous host, Proc Natl Acad Sci USA, 92, 11810, 10.1073/pnas.92.25.11810 · DOI · Paper page
- Old, 1998, New paths in human cancer serology, J Exp Med, 187, 1163, 10.1084/jem.187.8.1163 · DOI · Paper page
- Zhang, 1998, A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China, Int J Epidemiol, 27, 574, 10.1093/ije/27.4.574 · doi:10.1093/ije/27.4.574
- Covini, 1996, Comparison of protocols for depleting anti-E. coliantibody in immunoblotting of recombinant antigens, J Immunol Methods, 190, 143, 10.1016/0022-1759(95)00288-X · doi:10.1016/0022-1759(95)00288-x
- Devereux, 1984, A comprehensive set of sequence analysis programs for the VAX, Nucleic Acids Res, 12, 387, 10.1093/nar/12.1Part1.387 · DOI · Paper page
- Huang, 1994, On global sequence alignment, Comput Appl Biosci, 10, 227
- Pfeffer, 1995, Efficient one-tube RT-PCR amplification of rare transcripts using short sequence-specific reverse transcription primers, Biotechniques, 18, 204
- Burd, 1994, Conserved structures and diversity of functions of RNA-binding proteins, Science, 265, 615, 10.1126/science.8036511 · DOI · Paper page
- Muller-Pillasch, 1997, Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein, Oncogene, 14, 2729, 10.1038/sj.onc.1201110 · DOI · Paper page
- Ross, 1997, Characterization of a β-actin mRNA zipcode-binding protein, Mol Cell Biol, 17, 2158, 10.1128/MCB.17.4.2158 · DOI · Paper page
- Pfaff, 1992, Characterization of a Xenopus oocyte factor that binds to a developmentally regulated cis-element in the TFIIIA gene, Dev Biol, 151, 306, 10.1016/0012-1606(92)90235-9 · DOI
- Siomi, 1993, The pre-mRNA binding K protein contains a novel evolutionarily conserved motif, Nucleic Acids Res, 21, 1193, 10.1093/nar/21.5.1193 · DOI · Paper page
- Hahm, 1993, Isolation of a murine gene encoding a nucleic acid-binding protein with homology to hnRNP K, Nucleic Acids Res, 21, 3894, 10.1093/nar/21.16.3894 · doi:10.1093/nar/21.16.3894
- Davidoff, 1992, Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers, Proc Natl Acad Sci USA, 89, 3439, 10.1073/pnas.89.8.3439 · DOI · Paper page
- Chen, 1998, Identification of multiple cancer/ testis antigens by allogeneic antibody screening of a melanoma cell line library, Proc Natl Acad Sci USA, 95, 6919, 10.1073/pnas.95.12.6919 · doi:10.1073/pnas.95.12.6919
Cited by
Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution
Taguchi, K., Motohashi, H., & Yamamoto, M. (2011) · Genes to Cells · doi:10.1111/j.1365-2443.2010.01473.x · Cited by 1,478
Zhang, H. L., Eom, T., Oleynikov, Y., Shenoy, S. M., Liebelt, D. A., Dictenberg, J. B., Singer, R. H., & Bassell, G. J. (2001) · Neuron · doi:10.1016/s0896-6273(01)00357-9 · Cited by 386
Degrauwe, N., Suvà, M.-L., Janiszewska, M., Riggi, N., & Stamenkovic, I. (2016) · Genes & Development · doi:10.1101/gad.287540.116 · Cited by 324
“Its expression has been reported in most tumors of the hepato-biliary system, including HCCs (Jeng et al. 2008; Hu et al. 2014), intrahepatic cholangiocarcinoma (Chen et al. 2013b), gallbladder carcinomas (Shi et al. 2013), and bile duct carcinomas (Levy et al. 2010), where it correlates with poor prognosis and invasi…”
BackgroundInfluentialSerum autoantibodies as biomarkers for early cancer detection
Tan, H. T., Low, J., Lim, S. G., & Chung, M. C. M. (2009) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.07396.x · Cited by 315
Autoantibodies to tumor‐associated antigens: reporters from the immune system
Tan, E. M., & Zhang, J. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00611.x · Cited by 309
Self-citationThe role of the oncofetal IGF2 mRNA-binding protein 3 (IGF2BP3) in cancer
Lederer, M., Bley, N., Schleifer, C., & Hüttelmaier, S. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.07.006 · Cited by 287
Farina, K. L., Hüttelmaier, S., Musunuru, K., Darnell, R., & Singer, R. H. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200206003 · Cited by 271
Zaenker, P., Gray, E. S., & Ziman, M. R. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.01.017 · Cited by 267
Hansen, T. V. O., Hammer, N. A., Nielsen, J., Madsen, M., Dalbaeck, C., Wewer, U. M., Christiansen, J., & Nielsen, F. C. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.10.4448-4464.2004 · Cited by 251
“IMP2 has diverged phylogenetically from IMP1 and IMP3 and has no known orthologues, but a splice variant p62 has been isolated from hepatic carcinoma (59).”
BackgroundHoo, L. S., Zhang, J. Y., & Chan, E. K. (2002) · Oncogene · doi:10.1038/sj.onc.1205625 · Cited by 201
“Double staining experiments using mouse fibroblast cell line 3T3 showed that rabbit anti-p62 (Zhang et al., 1999) gave very similar diffuse cytoplasmic staining as mouse anti-p90 (Figure 4b – e) and human anti-p90 serum GC28 (Figure 4f – h).”
BackgroundMethodSelf-citationThe Diverse Functions of IMP2/IGF2BP2 in Metabolism
Dai, N. (2020) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2020.05.007 · Cited by 114
Overexpression of the IGF2-mRNA binding protein p62 in transgenic mice induces a steatotic phenotype
Tybl, E., Shi, F.-D., Kessler, S. M., Tierling, S., Walter, J., Bohle, R. M., Wieland, S., Zhang, J., Tan, E. M., & Kiemer, A. K. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.08.034 · Cited by 65
“During the past 20 years a rise in HCC incidence has been noticed, which is associated with metabolic risk factors like obesity, diabetes mellitus, non-alcoholic fatty liver disease (NAFLD), and non-alcoholic steatohepatitis (NASH) [1].”
InfluentialSelf-citationOverexpression of HCC1/CAPERα may play a role in lung cancer carcinogenesis
Chai, Y., Liu, X., Dai, L., Li, Y., Liu, M., & Zhang, J.-Y. (2014) · Tumor Biology · doi:10.1007/s13277-014-1819-y · Cited by 42
Self-citationXing, M., Li, P., Wang, X., Li, J., Shi, J., Qin, J., Zhang, X., Ma, Y., Francia, G., & Zhang, J.-Y. (2019) · Cancers · doi:10.3390/cancers12010007 · Cited by 39
Self-citationp62/IMP2 stimulates cell migration and reduces cell adhesion in breast cancer
Li, Y., Francia, G., & Zhang, J.-Y. (2015) · Oncotarget · doi:10.18632/oncotarget.5328 · Cited by 36
Self-citationLiu, W., Li, Z., Xu, W., Wang, Q., & Yang, S. (2013) · Scandinavian Journal of Immunology · doi:10.1111/sji.12032 · Cited by 33
Czepukojc, B., Abuhaliema, A., Barghash, A., Tierling, S., Naß, N., Simon, Y., Körbel, C., Cadenas, C., van Hul, N., Sachinidis, A., et al. (2019) · Frontiers in Medicine · doi:10.3389/fmed.2019.00179 · Cited by 20
Evaluation of serum autoantibody levels in the diagnosis of ovarian endometrioma
Yi, Y., Wang, S., Chao, C., Su, C., Lee, Y., & Chen, L. (2010) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.20415 · Cited by 12
IMPlications of IMP2 in RNA Biology and Disease
Das, J., Busia-Bourdain, O., Khan, K. M., & Wolfe, A. L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062415 · Cited by 3
“…was nearly identical to the p62 protein but included an additional insertion of 43 amino acids, representing a second splice isoform of IGF2BP2 [5]. target for immuno-oncology, while pharmacological inhibition of IMP2 is emerging as a strategy to mitigate the myriad e ff ects of this versatile…”
Metadata
- Authors
- Zhang, J.-Y., Chan, E. K. L., Peng, X.-X., & Tan, E. M.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1999-04-05
- Volume
- 189
- Issue
- 7
- Pages
- 1101-1110
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2136902996
- Cited by
- 202
- References
- 1
- FWCI
- 6.85
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.